Cargando…

Restoring the Angiogenic Capacity of the Human Diabetic Adipose-derived mesenchymal stem cells Primed with Deferoxamine as a Hypoxia Mimetic Agent: Role of HIF-1α

Purpose: Insufficient angiogenesis is associated with serious diabetic complications. Recently, adipose-derived mesenchymal stem cells (ADScs) are known to be a promising tool causing therapeutic neovascularization. However, the overall therapeutic efficacy of these cells is impaired by diabetes. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tajali, Raziye, Eidi, Akram, Ahmadi Tafti, Hosein, Pazouki, Abdolreza, Sharifi, Ali Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tabriz University of Medical Sciences 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278222/ https://www.ncbi.nlm.nih.gov/pubmed/37342375 http://dx.doi.org/10.34172/apb.2023.021

Ejemplares similares

Hypoxia mimetics restore bone biomineralisation in hyperglycaemic environments
por: Rezaei, Azadeh, et al.
Publicado: (2022)

NUPR1 acts as a pro-survival factor in human bone marrow-derived mesenchymal stem cells and is induced by the hypoxia mimetic reagent deferoxamine
por: Matsunaga, Kazuhito, et al.
Publicado: (2019)

Angiogenic Capacity of Periodontal Ligament Stem Cells Pretreated with Deferoxamine and/or Fibroblast Growth Factor-2
por: Ratajczak, Jessica, et al.
Publicado: (2016)

Insight in Hypoxia-Mimetic Agents as Potential Tools for Mesenchymal Stem Cell Priming in Regenerative Medicine
por: Nowak-Stępniowska, Agata, et al.
Publicado: (2022)

Restoring the Secretory Function of Irradiation-Damaged Salivary Gland by Administrating Deferoxamine in Mice
por: Zhang, Junye, et al.
Publicado: (2014)

Deferoxamine Treatment Combined With Sevoflurane Postconditioning Attenuates Myocardial Ischemia-Reperfusion Injury by Restoring HIF-1/BNIP3-Mediated Mitochondrial Autophagy in GK Rats
por: Yang, Long, et al.
Publicado: (2020)

Comparison of contrast sensitivity in β-thalassemia patients treated by deferoxamine or deferasirox
por: Ghazanfari, Azam, et al.
Publicado: (2019)

Hypoxia Mimetic Agents for Ischemic Stroke
por: Davis, Charles K., et al.
Publicado: (2019)

Local Injection of Deferoxamine Improves Neovascularization in Ischemic Diabetic Random Flap by Increasing HIF-1α and VEGF Expression
por: Wang, Chen, et al.
Publicado: (2014)

Comparison of random and aligned PCL nanofibrous electrospun scaffolds on cardiomyocyte differentiation of human adipose-derived stem cells
por: Safaeijavan, Raheleh, et al.
Publicado: (2014)

Hypoxia-Mimetic CoCl(2) Agent Enhances Pro-Angiogenic Activities in Ovine Amniotic Epithelial Cells-Derived Conditioned Medium
por: Di Mattia, Miriam, et al.
Publicado: (2022)

Deferoxamine has the Potential to Improve the COVID-19-Related Inflammatory Response in Diabetic Patients
por: Zeinivand, Motahareh, et al.
Publicado: (2023)

Angiogenic Potential of VEGF Mimetic Peptides for the Biofunctionalization of Collagen/Hydroxyapatite Composites
por: Wang, Suya, et al.
Publicado: (2021)

Small-bowel obstruction after modified jejunoileal bypass surgery due to gallstone ileus
por: Kermansaravi, Mohammad, et al.
Publicado: (2019)

Comparison of the effects of deferasirox, deferoxamine, and combination of deferasirox and deferoxamine on an aplastic anemia mouse model complicated with iron overload
por: Wu, Dijiong, et al.
Publicado: (2018)

The Role of Biomaterials as Angiogenic Modulators of Spinal Cord Injury: Mimetics of the Spinal Cord, Cell and Angiogenic Factor Delivery Agents
por: Rocha, Luís A., et al.
Publicado: (2018)

Hypoxia and hypoxia-mimetics attenuate the inflammatory response during murine endotoxemia
por: Kiers, D, et al.
Publicado: (2015)

Hypoxia and hypoxia mimetics differentially modulate histone post-translational modifications
por: Hsu, Kuo-Feng, et al.
Publicado: (2020)

Preconditioning of adipose tissue-derived mesenchymal stem cells with deferoxamine increases the production of pro-angiogenic, neuroprotective and anti-inflammatory factors: Potential application in the treatment of diabetic neuropathy
por: Oses, Carolina, et al.
Publicado: (2017)

Comparison of iron chelation effects of deferoxamine, deferasirox, and combination of deferoxamine and deferiprone on liver and cardiac T2* MRI in thalassemia maior
por: Ansari, Shahla, et al.
Publicado: (2017)

Model-Based Optimisation of Deferoxamine Chelation Therapy
por: Bellanti, Francesco, et al.
Publicado: (2015)

Abstract: Deferoxamine Increases Breast Cancer Radiosensitivity
por: Ranganathan, Kavitha, et al.
Publicado: (2018)

Mechanisms of Intranasal Deferoxamine in Neurodegenerative and Neurovascular Disease
por: Kosyakovsky, Jacob, et al.
Publicado: (2021)

Deferoxamine Reduces Inflammation and Osteoclastogenesis in Avulsed Teeth
por: Lee, Ko Eun, et al.
Publicado: (2021)

Iron Neurotoxicity and Protection by Deferoxamine in Intracerebral Hemorrhage
por: Li, Zhe, et al.
Publicado: (2022)

Impairment of hypoxia-induced angiogenesis by LDL involves a HIF-centered signaling network linking inflammatory TNFα and angiogenic VEGF
por: Jin, Fengyan, et al.
Publicado: (2019)

Could Local Application of Hypoxia Inducible Factor 1-α Enhancer Deferoxamine Be Promising for Preventing of Medication-Related Osteonecrosis of the Jaw?
por: Yalcin-Ülker, Gül Merve, et al.
Publicado: (2023)

Myocardial Hypertrophy Overrides the Angiogenic Response to Hypoxia
por: Choi, Yeong-Hoon, et al.
Publicado: (2008)

Modulation of Angiogenic and Inflammatory Response in Glioblastoma by Hypoxia
por: Murat, Anastasia, et al.
Publicado: (2009)

Hypoxia-Inducible Factor as an Angiogenic Master Switch
por: Hashimoto, Takuya, et al.
Publicado: (2015)

Deferoxamine inhibition of malaria is independent of host iron status
Publicado: (1988)

Comparison of the effect of vanadium and deferoxamine on acetaminophen toxicity in rats
por: Najafzadeh, H., et al.
Publicado: (2011)

Iron Accumulates in Huntington’s Disease Neurons: Protection by Deferoxamine
por: Chen, Jianfang, et al.
Publicado: (2013)

Deferoxamine therapy for intracerebral hemorrhage: A systematic review
por: Zeng, Liling, et al.
Publicado: (2018)

Effects of Deferoxamine on Leukemia In Vitro and Its Related Mechanism
por: Yang, Yujing, et al.
Publicado: (2018)

The effect of deferoxamine injection on composite graft survival in rabbits
por: Ramli, Rianto Noviady, et al.
Publicado: (2020)

The iron chelator deferoxamine decreases myeloma cell survival
por: Yang, Feifei, et al.
Publicado: (2021)

Effects of deferoxamine on intrinsic colistin resistance of Proteus mirabilis
por: Erinmez, Mehmet, et al.
Publicado: (2023)

HIF repressors under chronic hypoxia
por: Luo, Weibo, et al.
Publicado: (2016)

Hypoxia/HIF Modulates Immune Responses
por: Chen, Yuling, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9nmfn0nsktp13sa85mkejg62jc